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Abstract 
 
The synthesis is described of an analogue of the locust CRF-like diuretic peptide in which 
methionine in positions 1,3, and 13 is replaced by isosteric methyl homoserine residues. This 
analogue has been tested for biological activity on Malpighian tubules in vitro, and feeding 
behaviour in vivo. It is highly active in stimulating fluid secretion and accumulation of cAMP 
in tubules, and on increasing the latency to feed and reducing meal duration. A 15 residue 
fragment from the C-terminus of the CRF-like peptide, Locmi-DP32-46, is fully active in the 
feeding assay, but has only weak ability to stimulate the accumulation of cAMP in tubules. 
Two smaller fragments, Locmi-DP32-37 and Locmi-DP41-46, were tested but neither had 
consistent biological activity in any of the assays used here. None of the peptides tested have 
any substantive activity in increasing cGMP in tubules. 
 
Keywords: Locust; Diuretic hormone; CRF-like peptide; cAMP; Feeding behaviour; Fluid secretion; 
Malpighian tubules; Methionine replacement 
 
 
1. Introduction 
 
In recent years, a number of diuretic hormones have been identified in insects. Although 
5-hydroxytryptamine may be the major diuretic hormone in Rhodnius [6], the majority of 
insect diuretic hormones are peptides and fall into two major categories: a family of peptides 
that shows partial sequence identity with vertebrate corticotropin releasing factor (CRF); and 
a family of shorter kinins [7]. The release of the CRF-related diuretic peptide during feeding 
in locusts is well-established (1,2), and this study is part of an ongoing investigation of the 
role of the CRF-related diuretic peptide as an endogenous regulator of feeding activity in 
locusts [11]. 
 
One of the problems that has been encountered in studying the biology of CRF-like 
peptides has been a lack of stability during storage of the purified natural peptides isolated 
from insects. With this in mind, the synthesis was undertaken of an analogue of Locmi-DP in 
which methionine residues at positions 1, 3 and 13 were replaced by the isosteric amino acid 
methyl-homoserine, resulting in a product that it was hoped would retain biological activity 
and be less susceptible to oxidation. This methyl-homoserine analogue was tested in a range 
of bioassays designed to determine its activity on the Malpighian tubules, and on feeding 
behaviour. Because preliminary experiments suggested that a peptide with a C-terminally 
derived sequence from Locmi-DP (Cys31-Locmi-DP31-46, used in preparing antibodies against 
Locmi-DP) was active on some aspects of feeding behaviour (unpublished observations), 
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some short fragments from the C-terminal sequence of the natural peptide were also tested for 
biological activity. 
 
2. Materials and Methods 
 
2.1 Locusts 
 
Locusta migratoria migratorioides (R & F) were reared in Birkbeck College at 30°C 
in a LD 12:12 h photocycle. They were fed with fresh grass and wheat seedlings, 
supplemented with dried bran flakes. To obtain Locusta nymphs of a known age for the 
behavioural assays, fourth instar nymphs were separated from the main stock and newly 
moulted fifth instars removed on a daily basis so that their ages were known. For 
measurement of fluid secretion or second messenger studies on Malpighian tubules, mature 
adult male Schistocerca gregaria L. were purchased from Peregrine Livefoods (Essex, UK). 
 
2.2 Preparation of extracts of corpora cardiaca and of purified natural Locmi-DP 
 
 Corpora cardiaca were dissected from mature adult locusts and used immediately, or 
frozen in liquid nitrogen stored at -20°C. In some trials, freshly made homogenates of corpora 
cardiaca were made in a simple saline (7.5g NaCl, 0.375g KCl per litre). Otherwise, corpora 
cardiaca were extracted in acidic methanol (87% methanol, 5% glacial acetic acid) and 
Locmi-DP isolated as described previously [12] except that the diuretic peptide was detected 
in HPLC fractions by the use of a non-competitive ELISA using commercially produced 
antiserum (Sigma Genosys, Cambridge, UK) against Cys31-Locmi-DP31-46 coupled to keyhole 
limpet haemocyanin. 
 
2.3 Behavioural assay 
 
Five-day-old nymphs of Locusta were separated from their food in the morning and 
kept without food for 4-5 h.  They were then injected between tergites four and five, with 
10 µl of one of the test solutions or the saline control. The nymphs were placed individually in 
17 x 12 x 4 cm clear plastic boxes that contained an aluminium perch and some freshly cut 
leaves from wheat seedlings. After 10 sec, the behaviour of the locusts was recorded at 
intervals of 30 sec. The following categories of behaviour were recorded: feeding (which 
included both ingestion and chewing), contacting food (contact of wheat with at least one fore 
or mid tarsus orlabial or maxillary palp), resting (no ingestion or chewing) and locomoting 
[23]. The data were analysed to calculate the latency to the time insects took a meal, and the 
duration of the meal.  A period of feeding of >2 min was defined as a meal and the end of a 
meal was defined by a period of >2 min of not feeding. The intervals used to define the start 
and end of a meal were based on log-survivorship analyses of feeding and non-feeding 
periods [21]. 
 
2.4 Radioimmunoassays of cyclic AMP and GMP 
 
Radioiodinated cyclic nucleotides, cAMP or cGMP, were prepared using 300 pmol of 
2'O- methyl ester of each cyclic nucleotide (Sigma) and 18.5 MBq [125-I] NaI (Amersham), 
using Chloramine T [25] and were separated [125-I] on a C18 Sep-Pak (Waters) with 40 % 
isopropanol as eluant. Estimated specific activity was approximately 55.5 TBq 
(=1500 Ci/mmol), and aliquots were stored –20 oC (usable for about 10-12 weeks after 
iodination). To determine the effect of methyl-homoserine-Locmi-DP on cAMP production, 
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the Malpighian tubules (5-6/ tube) of S. gregaria were incubated for 30 min at room 
temperature with 100 μl of locust saline (140mM NaCl; 10mM KCl; 4mM CaCl2; 6mM 
NaH2PO4; 4mM NaHCO3; Sucrose 90mM; and pH 6.8) containing an appropriate 
concentration of peptide (or for controls, saline alone, and extracts of corpora cardiaca for use 
as a positive control), in the presence of 1 mM of 3-isobuty-1-lmethylxanthine (IBMX, 
Sigma). At the end of incubation, the tissues were sonicated for 10 sec (MSC, UK) and 
centrifuged at 14000 rpm for 10 min at 4oC.  The whole of the supernatant was taken into a 
tube containing 900 μl of 0.1 M acetate buffer (pH 4.75) and acetylated [5]. Aliquots (50 μl) 
of acetylated standard or unknown were added to tubes containing [125I] cAMP (25,000dpm 
/25 μl) and 25 μl of antiserum (a generous gift from Dr. J. de Vente, Maastricht, and used at a 
final dilution 1:7000) to give 150 μl as a final volume, and incubated overnight at 4 oC. The 
separation of bound from unbound cyclic nucleotide was carried out using secondary donkey 
anti-rabbit IgG (Sal-Cel, Immunodiagnostic Services) as described previously [25], and 
estimated using a gamma counter (Wallac 1270).  The results were expressed as fmol of either 
cAMP or cGMP/ tube.  
 
2.5 Fluid secretion assay 
 
Malpighian tubules were dissected from adult S. gregaria and freed from trachea in a 
locust saline (168 mM NaCl, 6.4 mM KCl, 3.6 mM MgCl2, 6 mM NaH2PO4, 2.1 mM 
NaHCO3, 2.1 mM CaCl2) to which medium 199 (GIBCO) had been added to a final 
concentration of 5% (v/v). Each tubule was then transferred into 20 μl of fresh medium and 
this was covered with water-saturated paraffin oil on a Sylgard® plate. One end of a tubule 
was pulled out of bathing medium and inserted into the right hand side of the Sylgard block, 
while the other end was inserted into the left hand side. A nick was then made by a pair of 
sharp forceps on the part of a tubule situated between the bathing medium and the right side 
of block.  The fluid droplet formed in the first 20 min was discarded. The fluid droplet 
secreted in the subsequent 20min was put on one side and used later to determine the initial 
basal level.  Then, 10μl of medium were removed from the bathing medium and replaced 
either by fresh saline or saline containing test material, and a fluid secretion droplet was 
collected for another 20 min. At end of the incubation, the diameters of the droplets were 
measured to calculate their volumes. Percentage changes in fluid secretion were calculated by 
dividing the volume of the second droplet by that of the first.  
 
2.6 Statistics 
 
Statistical significance of results was estimated at P <0.05 using STATVIEW 
(ANOVA). Curves of dose response data were fitted using SigmaPlot 5 (SPCC Inc.). Feeding 
behaviour was analysed using the non-parametric Mann-Whitney U test (SPSS) 
  
2.7 Peptide synthesis 
 
Purity of the synthesized peptides was estimated by reverse phase high performance 
liquid chromatography (RP-HPLC) and retention times (tR) were measured on Nucleosil C18 
column 250 X 4.6mm with the following solvent systems and conditions: (S1) linear gradient 
from 20-100% acetonitrile containing 0.05% TFA over 30 min., (S2) linear gradient from 10-
60% acetonitrile containing 0.05% TFA over 30 min., (S3) linear gradient from 5-35% 
acetonitrile containing 0.05% TFA over 30 min. UV detection at 214 nm, flow rate 1 ml/min. 
Purification of peptides was performed on a RP-HPLC Nucleosil C18 column 250 X 10 mm 
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with the following solvent system and conditions: linear gradient from 20-100% acetonitrile 
containing 0.05% TFA over 70 min;  UV detection at 225 nm and a flow rate of  3 ml/min.  
The strategy for the synthesis of [Hse(CH3)1, Hse(CH3)3, Hse(CH3)13 ]-Locmi-DP, 2, 
involved the synthesis of protected peptide acid fragments (Fig. 2) in the solid phase and their 
successive coupling to the C-terminal octapeptide of Locmi-DP attached to the Rink resin 
(Fig. 2). Protected peptide acids were synthesized in the solid phase and on the 2-chlorotriyl-
resin, OCLTR [3] using the Fmoc/t-Bu strategy. Fmoc-AA-OCLTR (1g, 0.5 mmol Fmoc-AA-
OH/g resin) was used for the solid phase synthesis of the peptide acids 6-10 and 12 (Fig. 2) 
and peptide chain elongation was performed with a procedure described previously [17,27]. 
The purity of the crude peptide acids was 88-92%, as estimated by HPLC.  
The C-terminal protected octapeptide 11 and hexapeptide 13 were synthesized on the 
Rink-2-chlorotrityl-resin [4] starting from Fmoc-Ile-Rink-OCTLR (1g, 0.13 mmol Fmoc-Ile-
OH/g of resin) and using exactly the protocol described previously [17,27]. 
The protected analogue of Locmi-DP, 2, was synthesized by successive coupling of 
the protected peptide acids 10, 9, 8, 7 and 6 to 11, using the protocol described for the 
protected peptide acids except that the benzotriazolylester of the peptides 6-10 was prepared 
as follows: the protected peptide acid (0.26 mmol) and HOBt (0.42 mmol) were dissolved in 
DMF (4 ml) at 0 oC and then DIC (0.29 mmol) was added and the solution containing the 
corresponding benzotriazolylester was poured into the solid phase reactor containing 
0.13 mmol of the amino component attached to the Rink linker-OCLTR, and the resultant 
suspension of the resin left to stand at room temperature for 24h. Completion of the acylation 
reaction was indicated by a negative Kaiser test. The final product 2 was obtained in two 
stages. In the first stage the protected peptide resin, after removing the Fmoc group, was 
stirred in 30 ml of TFE/DCM (3:7 v/v) for 3.5 h. Then the resin was filtered and washed three 
times with 10 ml of the above mixture. The combined filtrates were concentrated in vacuo and 
the residue solidified by addition of dry ether to yield the corresponding side chain protected 
peptide attached to the Rink linker. In the second stage, the linker and the side chain 
protecting groups were removed by treating the above peptide-Rink linker with 20 ml of 
TFA/DCM/anisole/EDTH/water, 70:18:4:6:2 v/v [24], for 4.5 h at room temperature. The 
solvent was then evaporated in vacuo and the residue solidified by addition of dry ether. The 
solid was filtered, dissolved in distilled water, and lyophilized. Purification of the crude 
peptide was performed by semi-preparative RP-HPLC to yield the desired product 2:  tR 
21.3 min. (S1); ESI-MS m/z: 1329.56 [M+4H]/4+, 1064.42 [M+5H]/5+, 887.21 [M+6H]/6+; 
MALDI-TOF MS: actual mass 5314.98Da calc. 5315.18Da. 
Following exactly the isolation procedure described for 2, the protected fragment 13 
yielded, Locmi-DP41-46, product 5: tR 9.0 min. (S2); ESI-MS m/z: 763 [M+H]+, 764 [M+2H]+, 
785 [M+Na]+. 
The synthesis of the decapentapeptide, Locmi-DP32-46, was undertaken independently 
of the synthesis of the methyl-homoserine analogue, 2, to allow comparison of its biological 
activity with that of Cys31-Locmi-DP31-46, which had been synthesized commercially by 
Sigma-Genosys Ltd (Cambridge, UK) as part of an earlier project to raise antibodies against 
Locmi-DP. The protected fragment Locmi-DP32-46, 3, was synthesized by coupling the 
protected peptide acid 12 to 11 as described for the fragment couplings of 2. The resulting 
fully protected Locmi-DP32-46 peptide fragment was treated exactly as the corresponding fully 
protected peptide 2 to yield the desired product 3: tR 15.6 min. (S3); ESI-MS m/z: 1775 
[M+H]+, 1776 [M+2H]+. 
The final product 4 was obtained from the protected peptide acid 12 attached to the 2-
chlorotrityl resin in two stages. In the first stage the Fmoc-group was removed and in the 
second stage the remaining peptide attached to the resin was stirred in 20 ml of 
TFA:H2O:anisole (95:3:2) for 1 h at room temperature. The solvent was then evaporated in 
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vacuo and the residue solidified by addition of dry ether. The solid was filtered, dissolved in 
distilled water, and lyophilized. Purification of the crude peptide was performed by semi-
preparative RP-HPLC to yield product 4: tR 11.0 min. (S3); ESI-MS m/z: 718 [M+H]+, 740 
[M+Na]+. 
 
3. Results 
 
3.1 The biological activity of the full peptide analogue 
 
For the synthesis of Hse(CH3)1,3,13-Locmi-DP, 2, the sequence of the target peptide 
was divided into five parts 6-10 (Fig. 2) which were synthesized as protected fragments in the 
solid phase on the 2-chlorotrityl resin. These products were obtained in high yield and purity, 
and were used without any further purification. Fragments were condensed successively to the 
amino component attached on the Rink linker-2-chlorotrityl resin 11 (Fig. 2). Low 
substitution (0.1-0.2 mmol/g of resin) of the amino component on the Rink linker-2-
chlorotrityl resin 11 was vital for completion of the acylation by the peptide acid fragments, 
which is why a two-molar excess was required instead of the three-molar excess used 
normally. 
 
The Hse(CH3)1,3,13-Locmi-DP synthesised here was active in three of the four assays in 
which it was tested. It stimulated fluid secretion by isolated Malpighian tubules (Fig. 3) in a 
dose-dependent manner, with an EC50 of c. 5 nmol l-1. In the assay that measured second 
messenger production by Malpighian tubules in vitro, the Hse(CH3)-analogue elicited a dose-
dependent accumulation of cAMP with an EC50 of c. 75 nmol l-1 (Fig. 4). The magnitude of 
the response elicited by a supramaximal concentration of the Hse(CH3)-analogue was 
comparable with that caused by an extract of corpora cardiaca (data not shown): it had no 
significant effect on the production of cGMP production by Malpighian tubules (Fig. 4). 
 
The methyl-homoserine analogue was also active in a behavioural bioassay. When 
compared with saline-injected control nymphs, the latency to the first meal (the period before 
locust nymphs contacted the wheat and started to feed) was significantly increased by the 
injection of the Hse(CH3)-analogue. The duration of the first meal was reduced significantly 
when as little as 150 fmol of the Hse(CH3)-analogue was injected (Fig.5). The reduction in 
meal duration brought about by the Hse(CH3)-analogue was comparable with that brought 
about by a sample of natural Locmi-DP (Fig. 5). 
 
3.2 The biological activity of C-terminal fragments 
 
Of the fragments tested in this study, only Locmi-DP32-46 had activity in the fluid 
secretion assay (Cys31-Locmi-DP31-46 was not tested), but this was very low, eliciting only 
about a 120% increase in the rate of secretion at a high concentration of 2 x 10-6 M. This 
peptide also showed very weak but statistically significant (P<0.005 at 10-5 M) stimulatory 
activity in cAMP production by Malpighian tubules, with a maximum response of only 
c. 35 fmol cAMP/tube; Locmi-DP41-46 was inactive, while Locmi-DP32-37 had some weak 
activity but showed no clear dose-response relationship (Fig. 6).  Two of the fragments 
appeared to have weak stimulatory activity on cGMP production when tested at a high dose of 
800 pmol per tube (Fig. 6), but this was not investigated further because the activity was very 
low when compared with the effect of an extract of corpora cardiaca, and was not a property 
shown by the full peptide (see Fig. 4). 
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The Cys31-Locmi-DP31-46 fragment was active in the behavioural assay. As little as 
150 fmol injected per nymph increased the latency to feed significantly to an extent 
comparable with the effect of natural Locmi-DP (Fig. 5).  Meal duration was also reduced by 
this short peptide but, while the methyl-homoserine-analogue and the natural Locmi-DP were 
active at 150 fmol, a significant effect on meal duration by Cys31-Locmi-DP31-46 was only 
observed when 1 pmol was injected (Fig. 5). 
 
The fragments Locmi-DP32-46, Locmi-DP32-37, and Locmi-DP41-46 were tested also in 
the behavioural assay. Only Locmi-DP32-46 showed consistent activity, increasing the latency 
to feed when as little as 150 fmol were injected, and decreasing the duration of meal; the latter 
response was significant, however, only when 1 pmol of peptide was injected (Fig. 7). The 
Locmi-DP32-37 fragment appeared initially (at 150 fmol injected) to have some activity in this 
assay, but this was not substantiated by the results of injections at higher doses (Fig. 7).    
  
4. Discussion 
 
Locmi-DP and other diuretic peptides have been synthesized in the solid phase and on 
various resins with the stepwise strategy either manually or by automated peptide synthesizers 
[1,10,14,15]. In the latest of these syntheses which is described in detail [14], almost all of the 
amino acid couplings had to be performed twice followed by acetylation for end-capping 
uncoupled chains. Thus a very low yield of the final product was obtained after appropriate 
purification. These results and the experience gained from the use of two acid sensitive resins 
for solid phase [13,17,24,27] prompted the adoption of a different strategy for the synthesis of 
diuretic peptides in this study. The synthesis described here is an improvement on those 
reported previously because it meets the requirements of high purity, and sufficient quantity 
of product at low cost to provide peptide material for the study of physiological function. This 
is due mainly to the nature of the resins used, the completion of amino acid and peptide 
couplings and the protection of the side chain of glutamines during the synthesis. A 46-amino 
acid analogue of Locmi-DP was synthesized in which Met at positions 1, 3 and 13 were 
replaced by the isosteric amino acid methyl-homoserine. This replacement was chosen 
because in most cases it does not affect the activity of the parent peptide [16] and, in addition, 
it would provide information on the importance of sulfur in the side chains of methionines on 
the biological activity of Locmi-DP.  
The methyl-homoserine analogue of Locmi-DP is highly active in the biological 
assays employed in this study. Its potency in stimulating cAMP production and fluid secretion 
by Malpighian tubules from Schistocerca gregaria is comparable with that reported for the 
endogenous CRF-like peptide assayed in tubules from Locusta [15]. The lack of effect of the 
analogue on cGMP production by tubules is consistent with what is known of the mechanism 
of action of Locmi-DP [7]. Although the stability of the methyl-homoserine analogue during 
storage has not been tested in a rigorous manner, we have no reason to suspect that it loses 
biological activity during long-term storage as a lyophilized powder at -20 °C: it retains 
potent biological activity, and HPLC analysis shows that it comprises a single major peak of 
UV-absorbing material, even after more than 18 months of storage under these conditions.  
The regulation of feeding in insects involves central excitation that is augmented 
positively by both food and non-food stimuli, both from within and outside the animal, and 
modulated by deterrent stimuli and by feedback from peripheral systems such as stretch 
receptors on the gut wall, hormones and blood composition [22]. Stretching of the foregut is 
one of the first consequences of food intake, and it is likely that this is a signal for the release 
of a number of chemical messengers, including diuretic factors like Locmi-DP [1,2] and 
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myotropins like locustasulfakinin [20,26], which may play a part in the regulation of food 
intake. 
The release of Locmi-DP appears to play a role in satiety; signaling the end of a meal 
in Locusta by reducing taste-receptor input from the maxillary palps [9,11]. The present study 
shows that Hse(CH3)1,3,13-Locmi-DP has the same effects as the parent peptide in influencing 
some aspects of feeding behaviour. Compared with saline-injected control nymphs, the 
latency to the first meal (the period before locust nymphs contact the wheat and start to feed) 
is significantly increased by the injection of the Hse(CH3)-analogue, and the duration of the 
first meal decreases. The active peptides are highly potent: injection of as little as 150 fmol is 
required (assuming a blood volume of c. 200 μl, this represents an effective concentration in 
the locust of c. 0.7 x 10-9 M). It is remarkable that this biological activity in regulating satiety 
in locusts [11] is retained in peptides derived from the C-terminal32-46 sequence of the 
hormone, because these small peptides have only weak activity on cAMP production or fluid 
secretion by Malpighian tubules. Furthermore, it is reported that Locmi-DP27-46 does not 
stimulate fluid secretion by Malpighian tubules [14]. More significantly, however, it has been 
reported previously that the first few residues at the N-terminus of Locmi-DP are important 
for receptor activation [8]. On the other hand, C-terminal fragments from the CRF-like 
diuretic peptide of Manduca sexta (Manse-DP), retain good binding affinity for the Manduca 
receptor, but do not stimulate cAMP production [18,19]. The exact mechanism by which 
Locmi-DP affects feeding behaviour is unknown, but it is thought to be a direct effect, at least 
in part, on the opening and closing of the apical pores on taste sensillae [11]: if this is so, then 
it seems that the structure-activity requirements of the relevant receptors for the diuretic 
peptide on these sensillae are different from those of the receptors in the Malpighian tubules. 
It is disappointing that the smaller fragments tested, especially Locmi-DP41-46, were not active 
in any of the assays. Work is now in progress to determine more systematically whether (and 
how far) the C-terminal 15-mer can be truncated N-terminally without loss of its effects on 
the feeding behaviour of locusts.   
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Figure 1. Locusta Diuretic Hormone (Lom-DP) and its synthesized analogues   
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Fmoc-Hse(CH3)-Gly-Hse(CH3)-Gly-Pro-OH 6, Fmoc-[1-5]-OH 
Fmoc-Ser(Bu-t)-Leu-Ser(Bu-t)-Ile-Val-Asn-Pro-OH  7, Fmoc-[6-12]-OH 
Fmoc-Hse(CH3)-Asp(OBu-t)-Val-Leu-Arg(Pbf)-Gln(Trt)-Arg(Pbf)-Leu-Leu-Leu-Glu(OBu-t)-OH   8, Fmoc-[13-23]-OH 
Fmoc-Ile-Ala-Arg(Pbf)-Arg(Pbf)-Arg(Pbf)-Leu-Arg(Pbf)-Asp(OBu-t)-Ala-Glu(OBu-t)-OH  9, Fmoc-[24-33]-OH 
Fmoc-Glu(OBu-t)-Gln(Trt)-Ile-Lys(Boc)-OH 10, Fmoc-[34-37]-OH 
H-Ala-Asn-Lys(Boc)-Asp(OBu-t)-Phe-Leu-Gln(Trt)-Gln(Trt)-Ile-Rink linker-OCLTR 11, H-[38-46]-Rink linker-OCTLR 
Fmoc-Ala-Glu(OBu-t)-Glu(OBu-t)-Gln(Trt)-Ile-Lys(Boc)-OH 12, Fmoc-[32-37}-OH 
H-Asp(OBu-t)-Phe-Leu-Gln(Trt)-Gln(Trt)-Ile-Rink linker-OCLTR 13, H-[41-46]-Rink linker-OCTLR 
 
Figure 2. Protected fragments used in the synthesis of [Hse(CH3)1, Hse(CH3)3, Hse(CH3)13]-Locmi-DP and of 
Locmi-DP32-46, Locmi-DP32-37,  Locmi-DP41-46
 12
 
Fig 3 The effect of Hse(CH3)1,3,13-Locmi-DP on fluid secretion in vitro by Malpighian tubules from Schistocerca. 
Points represent the mean ± SE (vertical bars):  n=5-8, the open circle is the saline control value.  
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Fig. 4. The effect of Hse(CH3)1,3,13-Locmi-DP on second messenger production in vitro by 
Malpighian tubules from Schistocerca. Points represent the mean ± SE (vertical bars): n=5 
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Fig. 5. The effects of Hse(CH3)1,3,13-Locmi-DP, Cys31-Locmi-DP31-46, and natural Locmi-DP, 
on latency to feed (upper bar chart) and duration of the first meal (lower bar chart) when 
nymphs of Locusta were presented with fresh wheat after 4-5 h of food deprivation. The bars 
represent the mean ± SE (vertical bars):  n=10-15, asterisk shows significant difference 
between control (0 dose, saline) and test peptide at P<0.05. 
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Fig. 6. The effects of Locmi-DP32-37, Locmi-DP41-46, and Locmi-DP32-46 on the production of 
cAMP and cGMP in vitro by Malpighian tubules from Schistocerca. In the assay for cGMP 
production (bar chart), each of the peptides was tested at 800 pmol per tube against an extract 
of corpora cardiaca (0.5 pairs per tube). In the assay for cAMP production (line graph) Locmi-
DP41-46 was inactive even at 800 pmol (data not shown), and addition of an extract of corpora 
cardiaca (0.5 pair of glands per tube) as a positive control (data not shown) resulted in a level 
of cAMP of 1390 ± 110 fmol per tube (n=5). Bars and data points represent the mean ± SE 
(vertical bars): n=4-6. 
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Fig. 7. The effects of Locmi-DP32-37, Locmi-DP41-46, and Locmi-DP32-46, on latency to feed 
(upper bar chart) and duration of the first meal (lower bar chart) when nymphs of Locusta 
were presented with fresh wheat after 4-5 h of food deprivation. The bars represent the mean 
± SE (vertical bars):  n=10-15, asterisk shows significant difference between control and test 
peptide at P<0.05. 
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